Skip to main content
Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
169.52
-0.48 (-0.28%)
Dec 20, 2024, 4:00 PM EST - Market closed

Masimo Revenue

Masimo had revenue of $504.60M in the quarter ending September 28, 2024, with 5.37% growth. This brings the company's revenue in the last twelve months to $2.04B, down -3.48% year-over-year. In the year 2023, Masimo had annual revenue of $2.05B with 0.60% growth.

Revenue (ttm)
$2.04B
Revenue Growth
-3.48%
P/S Ratio
4.41
Revenue / Employee
$537,526
Employees
3,800
Market Cap
9.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 30, 20232.05B12.30M0.60%
Dec 31, 20222.04B796.60M64.28%
Jan 1, 20221.24B95.50M8.35%
Jan 2, 20211.14B205.86M21.95%
Dec 28, 2019937.84M79.55M9.27%
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Jan 2, 2016 Pro Pro Pro
Jan 3, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Henry Schein 12.50B
Encompass Health 5.22B
Charles River Laboratories International 4.06B
Bruker 3.24B
Bio-Rad Laboratories 2.58B
Bio-Rad Laboratories 2.58B
Penumbra 1.16B
Intra-Cellular Therapies 613.73M
Revenue Rankings

MASI News

More News